Home > PB Ratio > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
PB (Price/Book ) Ratio

The Current P/B Ratio of GLENMARK LIFE SCIENCES is 5.54.

Share Price ₹1,048.9Nov 22,2024
Market Cap ₹12,849.0 Cr
Book Value₹2,321.3 CrMar2024 - Standalone Results
Price/Book 5.54xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results
GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PB (Price/Book ) ratio of GLENMARK LIFE SCIENCES

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of GLENMARK LIFE SCIENCES is calculated as :

Current Market Cap [ ₹12,849.0 Cr] as on Nov 22,2024

(/) Book Value [ ₹2,321.3 Cr] based on Mar2024 - Standalone Results

(=) P/B Ratio [ 5.54x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for GLENMARK LIFE SCIENCES , the investors are currently willing to pay '5.54 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of GLENMARK LIFE SCIENCES !

The chart below summarizes the trend in P/B Ratio of GLENMARK LIFE SCIENCES over the last five years.

Historical PB (Price/Book ) ratio chart of GLENMARK LIFE SCIENCES


PB Ratio Performance Analysis for GLENMARK LIFE SCIENCES

- GLENMARK LIFE SCIENCES 's latest p/b ratio is 5.54x.

- GLENMARK LIFE SCIENCES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.82x.

- GLENMARK LIFE SCIENCES 's operated at median p/b ratio of 2.25x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLENMARK LIFE SCIENCES 's p/b ratio peaked in Mar2024 at 4.09x.

- GLENMARK LIFE SCIENCES 's p/b ratio hit its five-year low in Mar2021 of 0x.


How does GLENMARK LIFE SCIENCES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
GLENMARK LIFE SCIENCES 2,321.265.5412,849.0
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.78431,352.0
CIPLA LTD26,619.904.51120,035.0
DR REDDYS LABORATORIES LTD28,123.503.60101,286.0
ZYDUS LIFESCIENCES LTD19,829.504.8195,461.4
DIVIS LABORATORIES LTD13,571.0011.74159,265.0
MANKIND PHARMA LTD9,339.8410.95102,231.0
TORRENT PHARMACEUTICALS LTD6,856.1515.65107,306.0
LUPIN LTD14,175.806.6694,430.6
AUROBINDO PHARMA LTD29,842.802.3871,069.8
ABBOTT INDIA LTD3,658.7316.0958,859.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs GLENMARK LIFE SCIENCES 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.38x
Max industry PB 16.09x
Median industry PB 6.66x
Average industry PB 8.06x



You may also like the below Video Courses